Cargando...
The chemokine CXCL12 mediates the anti-amyloidogenic action of painless human nerve growth factor
Nerve growth factor is a therapeutic candidate for Alzheimer’s disease. Due to its pain-inducing activity, in current clinical trials nerve growth factor is delivered locally into the brain by neurosurgery, but data on the efficacy of local nerve growth factor delivery in decreasing amyloid-β deposi...
Gardado en:
| Publicado en: | Brain |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Oxford University Press
2017
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5379860/ https://ncbi.nlm.nih.gov/pubmed/28031222 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/brain/aww271 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|